-
March 14: The Week in Cancer News
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
by Kevin McLaughlin
-
March 7: The Week in Cancer News
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
by Thomas Celona
-
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
February 28: The Week in Cancer News
Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.
by Eric Fitzsimmons
-
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
-
February 21: The Week in Cancer News
Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.
by Marci A. Landsmann
-
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
-
February 14: The Week in Cancer News
Pesticide firms try to block cancer-related lawsuits, and cancer pain leads to greater tobacco and cannabis use.
by Kevin McLaughlin
-
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
February 7: The Week in Cancer News
Researchers explore musical toxicity from cancer treatment, and kidney cancer vaccine shows potential in early trial.
by Eric Fitzsimmons
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona